245
Participants
Start Date
December 28, 2020
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2030
Trastuzumab deruxtecan
T-DXd: administered as an IV infusion
Durvalumab
Durvalumab: administered as an IV infusion
Paclitaxel
Paclitaxel: administered as an IV infusion
Pertuzumab
Pertuzumab: administered as an IV infusion
Tucatinib
Tucatinib administered orally (tablet) twice daily
Research Site, Taipei
Research Site, Rome
Research Site, Taipei
Research Site, Taoyuan
Research Site, Tainan City
Research Site, Hualien City
Research Site, Melbourne
Research Site, Ankara
Research Site, New York
Research Site, Taipei
Research Site, New York
Research Site, Taipei
Research Site, Harrison
Research Site, Taipei
Research Site, Commack
Research Site, Milan
Research Site, Edirne
Research Site, Fairfax
Research Site, Madrid
Research Site, Madrid
Research Site, St. Petersburg
Research Site, Fort Myers
Research Site, Istanbul
Research Site, Istanbul
Research Site, Izmir
Research Site, Nashville
Research Site, Bologna
Research Site, Seville
Research Site, Columbus
Research Site, Fort Worth
Research Site, Napoli
Research Site, München
Research Site, Villejuif
Research Site, Würzburg
Research Site, Moscow
Research Site, Moscow
Research Site, Delhi
Research Site, Moscow
Research Site, Moscow
Research Site, Moscow
Research Site, Moscow
Research Site, Gūrgaon
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Mumbai
Research Site, Madurai
Research Site, Barretos
Research Site, Belo Horizonte
Research Site, Natal
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, São Paulo
Research Site, Sorocaba
Research Site, Montreal
Research Site, Québec
Research Site, Toronto
Research Site, Bydgoszcz
Research Site, Koszalin
Research Site, Lodz
Research Site, Lublin
Research Site, Busan
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Buckhurst Hill
Lead Sponsor
Daiichi Sankyo Company, Limited
UNKNOWN
AstraZeneca
INDUSTRY